Goodness Growth Holdings Dirección

Dirección controles de criterios 2/4

El CEO de Goodness Growth Holdings' es Josh Rosen, nombrado en Feb 2023, tiene una permanencia de 1.17 años. posee directamente un 0.014% de las acciones de la empresa, con un valor de CA$11.40K. La antigüedad media del equipo directivo y de la junta directiva es de 4.4 años y 3.8 años, respectivamente.

Información clave

Josh Rosen

Chief Executive Officer (CEO)

US$657.3k

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	1.3yrs
Participación del CEO	0.01%
Permanencia media de la dirección	4.5yrs
Promedio de permanencia en la Junta Directiva	3.9yrs

Actualizaciones recientes de la dirección

Recent updates

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Jan 25

Vireo Health International's (CSE:VREO) Shareholders Are Down 55% On Their Shares

Sep 04

CEO

Josh Rosen (49 yo)

1.3yrs

Permanencia

US$657,289

Compensación

Mr. Joshua Nathaniel Rosen, also known as Josh, serves as Chief Executive Officer at Goodness Growth Holdings, Inc. and served as Interim Chief Executive Officer since February 2023 and serves as its Inter...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kyle Kingsley	Founder & Executive Chairman	9.8yrs	US$1.59m	4.57% $ 4.3m
Joshua Rosen	CEO, Interim CFO & Director	1.3yrs	US$657.29k	0.014% $ 13.0k
Eric Greenbaum	Chief Scientific Officer	3.3yrs	sin datos	sin datos
Sam Gibbons	Vice President of Investor Relations	5.3yrs	sin datos	sin datos
Albert Zakes	Vice President of Corporate Communications	no data	sin datos	sin datos
Harris Rabin	Chief Marketing Officer	2.7yrs	sin datos	sin datos
Stephen Dahmer	Chief Medical Officer	8.7yrs	US$320.15k	sin datos
Patrick Peters	Executive Vice President of Retail	4.5yrs	sin datos	sin datos

4.5yrs

Permanencia media

47.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de GDNS se considera experimentado (4.4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kyle Kingsley	Founder & Executive Chairman	9.8yrs	US$1.59m	4.57% $ 4.3m
Joshua Rosen	CEO, Interim CFO & Director	2.8yrs	US$657.29k	0.014% $ 13.0k
Judd Nordquist	Independent Director	5.2yrs	US$270.50k	0.059% $ 54.9k
Victor Mancebo	Independent Director	3.3yrs	US$220.32k	0% $ 0
Amber Shimpa	President & Director	no data	US$758.80k	0.61% $ 569.2k
Ross Hussey	Independent Director	3.9yrs	US$220.40k	1.17% $ 1.1m

3.9yrs

Permanencia media

45.5yo

Promedio de edad

Junta con experiencia: GDNS's board of directors are considered experienced (3.9 years average tenure).

Goodness Growth Holdings Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Goodness Growth Holdings, Inc. Announces CFO Changes

Goodness Growth Holdings, Inc. Announces Management Changes

Goodness Growth Holdings, Inc. Announces Departure of Christian Gonzalez-Ocasio as Chief Operating Officer

Recent updates

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Goodness Growth Holdings, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.33 loss in FY 2022)

Goodness Growth Holdings, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.066 loss in 3Q 2022)

Goodness Growth Holdings, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Goodness Growth Holdings, Inc. Announces CFO Changes

New major risk - Financial position

Second quarter 2023 earnings released: US$0.084 loss per share (vs US$0.048 loss in 2Q 2022)

Goodness Growth Holdings, Inc. to Report Q2, 2023 Results on Aug 14, 2023

New minor risk - Shareholder dilution

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.11 loss in 1Q 2022)

Goodness Growth Holdings, Inc. to Report Q1, 2023 Results on May 15, 2023

Goodness Growth Holdings, Inc. Announces Management Changes

Price target decreased to CA$0.85

Goodness Growth Holdings, Inc. Announces Departure of Christian Gonzalez-Ocasio as Chief Operating Officer

Goodness Growth Holdings, Inc Appoints Josh Rosen to the Role of Interim President

Goodness Growth Holdings, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Goodness Growth Holdings, Inc., Annual General Meeting, Nov 18, 2022

Goodness Growth Holdings, Inc. Announces Launch of Boundary Waters Pre-Rolls in Minnesota

Second quarter 2022 earnings released: US$0.048 loss per share (vs US$0.044 loss in 2Q 2021)

Goodness Growth Holdings, Inc. Announces Unaudited and Condensed Impairment Results for the Quarter Ended June 30, 2022

Goodness Growth Holdings, Inc. Launches Cannabis-Infused Gummies in Minnesota

Goodness Growth Holdings Launches Hicolor™ Cannabis Chews in New York

First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.059 loss in 1Q 2021)

Goodness Growth Holdings, Inc. Reports Consolidated Impairment of Long-Lived Assets for the Three Months Ended March 31, 2022

Price target increased to CA$4.00

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Price target increased to CA$4.00

Verano Holdings Corp. (CNSX:VRNO) entered into a definitive arrangement to acquire Goodness Growth Holdings, Inc. (CNSX:GDNS) for approximately $300 million.

Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Goodness Growth Holdings Launches New Line of Cannabis Edibles

Third quarter 2021 earnings released: US$0.078 loss per share (vs US$0.004 loss in 3Q 2020)

Price target decreased to CA$4.00

Goodness Growth Holdings, Inc. Retail Brand Green Goods® to Offer Medical Cannabis Program Information & Discounts At the Minnesota State Fair

Second quarter 2021 earnings released: US$0.044 loss per share (vs US$0.16 loss in 2Q 2020)

Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Goodness Growth Holdings Subsidiary Resurgent Biosciences Announces Planned Expansion into Psychedelics Research and Ip Development

Vireo Health International, Inc. Provides Revenue Guidance for the Fiscal Year 2022

First quarter 2021 earnings released: US$0.062 loss per share (vs US$0.076 loss in 1Q 2020)

Vireo Health Expands Ground Cannabis Flower in New York, Offers Largest Selection of Ground Flower At Any New York Dispensary

Insider recently sold CA$4.6m worth of stock

Full year 2020 earnings released: US$0.23 loss per share (vs US$0.67 loss in FY 2019)

Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Vireo Health International, Inc. to Report Q4, 2020 Results on Mar 25, 2021

New 90-day high: CA$3.77

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Vireo Health International Inc. Appoints Victor E. Mancebo to its Board of Directors

Price target raised to CA$2.33

New 90-day high: CA$3.09

Vireo Health International, Inc. Launches Amplifi™, the First Terpene-Enhanced Brand of Dry Cannabis Flower

Vireo Health International, Inc. (CNSX:VREO) completed the acquisition of medical and adult-use cannabis cultivation and processing businesses in Nevada.

New 90-day high: CA$1.75

Insider recently sold CA$708k worth of stock

Insider recently sold CA$946k worth of stock

New 90-day high: CA$1.73

Revenue beats expectations

Vireo Health International, Inc. Announces Executive Promotions

Jushi Holdings Inc. (OTCPK:JUSH.F) acquired Pennsylvania Dispensary Solutions, LLC from Vireo Health International, Inc. (CNSX:VREO) for $5 million.

Vireo Health International, Inc. to Report Q3, 2020 Results on Nov 25, 2020

Insider recently sold CA$338k worth of stock

New 90-day high: CA$1.58

Vireo Health International, Inc. (CNSX:VREO) agreed to acquire a medical and adult-use cannabis cultivation and processing businesses in Nevada.

Insider recently sold CA$344k worth of stock